BRAIN Biotech Aktie
3,52EUR | -0,03EUR | -0,85% |
WKN DE: 520394 / ISIN: DE0005203947
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 46,28 |
Martin Putsch | 45,40 |
Daniel Hopp | 5,60 |
Gabriele Sachse | 2,72 |
APO Medical Opportunities | 2,25 |
APO VV Premium Privat | 2,25 |
Wydler Global Equity Fund | 2,10 |
Berenberg - 1590 - Aktien Mittelstand | 1,58 |
MEAG ProInvest | 1,51 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 281 | 279 | 288 | 309 | 309 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,14 | 0,14 | 0,13 | 0,16 | 0,18 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 31 | 33 | 39 | 30 | 25 |
Summe Anlagevermögen | 35 | 39 | 39 | 48 | 45 |
Summe Aktiva | 66 | 72 | 78 | 78 | 71 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 49 | 46 | 36 | 44 | 48 |
Summe Eigenkapital | 17 | 26 | 42 | 34 | 23 |
Summe Passiva | 66 | 72 | 78 | 78 | 71 |
Adresse
Darmstädter Strasse 34-36, 64673 Zwingenberg | |
Telefon | +49 (6251) 9331-0 |
Internet | http://www.brain-biotech.de |
Management
Adriaan Moelker
Chief Executive Officer |
Alexander Pelzer
Head-Research & Development |
Anna Carina Eichhorn
Vice Chairman-Supervisory Board |
Christine Uekert
Independent Member-Supervisory Board |
Erik de Vries
Senior Director-Business Development |
Florian Schnabel
Independent Member-Supervisory Board |
Martin Langer
EVP & Managing Director-BioScience Operations |
Martina Schuster
Head-Investor Relations |
Michael Majerus
Chairman-Supervisory Board |
Michael Schneider
Chief Financial Officer |
Stephen Catling
Independent Member-Supervisory Board |
Thomas Kessler
Executive Vice President & Unit Head-Cosmetics |
Ute Dechert
Vice President-Human Resources & Processes |